Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-189
Closed -$6.24K – 491
2025
Q1
$6.24K Buy
+189
New +$6.16K ﹤0.01% 979
2017
Q2
– Sell
-4,250
Closed -$249K – 478
2017
Q1
$249K Hold
4,250
– – 0.01% 430
2016
Q4
$236K Sell
4,250
-750
-15% -$40.1K 0.01% 443
2016
Q3
$235K Sell
5,000
-750
-13% -$35.7K 0.01% 478
2016
Q2
$249K Sell
5,750
-750
-12% -$30.9K 0.01% 450
2016
Q1
$222K Hold
6,500
– – 0.01% 479
2015
Q4
$516K Hold
6,500
– – 0.02% 373
2015
Q3
$381K Hold
6,500
– – 0.01% 446
2015
Q2
$418K Hold
6,500
– – 0.01% 458
2015
Q1
$396K Sell
6,500
-2,000
-24% -$137K 0.01% 447
2014
Q4
$498K Buy
+8,500
New +$433K 0.02% 407

Other funds holding ALKS

SVB Wealth's ALKS Position: Q2 2025 in Review

SVB Wealth sold out of Alkermes (ALKS) in Q2 2025, closing a stake of 189 shares — an estimated $6.24K sold.

SVB Wealth first reported a position in ALKS in Q4 2014 and held it in 11 quarters. The position peaked at $516K in Q4 2015. 353 funds tracked by Wall St. Rank hold ALKS as of Q2 2025.

  • SVB Wealth reported no remaining Alkermes position as of Q2 2025 after selling out during the quarter.
  • SVB Wealth sold 189 Alkermes shares in Q2 2025, an estimated $6.24K.
  • SVB Wealth first reported a position in Alkermes in Q4 2014 and held it in 11 quarters.
  • SVB Wealth's Alkermes position peaked at $516K in Q4 2015.
  • 353 funds tracked by Wall St. Rank held Alkermes as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.